Development of selective inhibitors and substrate of matrix metalloproteinase-12

被引:133
作者
Devel, L
Rogakos, V
David, A
Makaritis, A
Beau, F
Cuniasse, P
Yiotakis, A
Dive, V
机构
[1] Ctr Etud Saclay, Dept Ingn & Etud Prot, Commissariat Energie Atom, F-91191 Gif Sur Yvette, France
[2] Univ Athens, Dept Organ Chem, Organ Chem Lab, GR-15771 Athens, Greece
关键词
D O I
10.1074/jbc.M600222200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four phosphinic peptide libraries with compounds having the general formula p-Br-Ph-(PO2-CH2)-Xaa'-Yaa'-Zaa'-NH2 have been prepared and screened against 10 matrix metalloproteinases ( MMPs). We identified two phosphinic peptides with K-i values of 0.19 and 4.4 nM toward MMP-12 ( macrophage elastase) that are more than 2 - 3 orders of magnitude less potent toward the other MMPs tested. These highly selective MMP-12 inhibitors contain a Glu-Glu motif in their Yaa'-Zaa' positions. Incorporation of this Glu-Glu motif into the sequence of a nonspecific fluorogenic peptide cleaved by MMPs provides a highly selective substrate for MMP-12. A model of one of these inhibitors interacting with MMP-12 suggests that the selectivity observed might be due, in part, to the presence of two unique polar residues in MMP-12, Thr(239) and Lys(177). These MMP-12-selective inhibitors may have important therapeutic applications to diseases in which MMP-12 has been suggested to play a key role, such as in emphysema, atherosclerosis, and aortic abdominal aneurysm.
引用
收藏
页码:11152 / 11160
页数:9
相关论文
共 55 条
[21]   Crystal structure of the Stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state [J].
Gall, AL ;
Ruff, M ;
Kannan, R ;
Cuniasse, P ;
Yiotakis, A ;
Dive, V ;
Rio, MC ;
Basset, P ;
Moras, D .
JOURNAL OF MOLECULAR BIOLOGY, 2001, 307 (02) :577-586
[22]   Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice [J].
Hautamaki, RD ;
Kobayashi, DK ;
Senior, RM ;
Shapiro, SD .
SCIENCE, 1997, 277 (5334) :2002-2004
[23]  
Hofmann HS, 2005, CLIN CANCER RES, V11, P1086
[24]   AN ACCURATE METHOD FOR DETERMINATION OF RECEPTOR LIGAND AND ENZYME-INHIBITOR DISSOCIATION-CONSTANTS FROM DISPLACEMENT CURVES [J].
HOROVITZ, A ;
LEVITZKI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (19) :6654-6658
[25]   Design, synthesis, and evaluation of a mechanism-based inhibitor for gelatinase A [J].
Ikejiri, M ;
Bernardo, MM ;
Meroueh, SO ;
Brown, S ;
Chang, M ;
Fridman, R ;
Mobashery, S .
JOURNAL OF ORGANIC CHEMISTRY, 2005, 70 (14) :5709-5712
[26]   Divergent effects of matrix metalloproteinase-3, metalloproteinase-7, metalloproteinase-9, and metalloproteinase-12 on atherosclerotic plaque stability in mouse brachiocephalic arteries [J].
Johnson, JL ;
George, SJ ;
Newby, AC ;
Jackson, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15575-15580
[27]   Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors [J].
Kannan, R ;
Ruff, M ;
Kochins, JG ;
Manly, SP ;
Stoll, I ;
El Fahime, M ;
Noël, A ;
Foidart, JM ;
Rio, MC ;
Dive, V ;
Basset, P .
PROTEIN EXPRESSION AND PURIFICATION, 1999, 16 (01) :76-83
[28]   Human macrophage metalloelastase (MMP-12) expression is induced in chondrocytes during fetal development and malignant transformation [J].
Kerkelä, E ;
Böhling, T ;
Herva, R ;
Uria, JA ;
Saarialho-Kere, U .
BONE, 2001, 29 (05) :487-493
[29]   A NOVEL COUMARIN-LABELED PEPTIDE FOR SENSITIVE CONTINUOUS ASSAYS OF THE MATRIX METALLOPROTEINASES [J].
KNIGHT, CG ;
WILLENBROCK, F ;
MURPHY, G .
FEBS LETTERS, 1992, 296 (03) :263-266
[30]   MMP-12 has a role in abdominal aortic aneurysms in mice [J].
Longo, GM ;
Buda, SJ ;
Fiotta, N ;
Xiong, WF ;
Griener, T ;
Shapiro, S ;
Baxter, BT .
SURGERY, 2005, 137 (04) :457-462